Marketing GSK, Gilead, Novo Nordisk join other Big Pharmas in honoring 2025 LGBTQ+ Pride Month By Andrea Park Jun 26, 2025 3:31pm LGBTQ+ Diversity Novo Nordisk Novartis ...

James Weldon Johnson’s poem “Lift Every Voice and Sing,” set to music by his brother John Rosamond, was first presented as a hymn, then adopted as a song and soon cherished as an anthem. In its 125th ...

Lip balm that shoppers say is ‘the best they’ve ever tried’ reduced at Sephora It delivers moisture relief to dry lips as well as refreshes with cinnamon leaf, clove and anise oils ...

Both events underscore Gilead's strength in innovation. Despite these developments, Gilead's share price remained flat over the past month, contrasting with the broader market's 1.9% rise in seven ...

In the world of Gilead, women’s bodies are no longer their own. Fertility becomes the regime’s currency and those who can bear children are forced into submission under the guise of religion ...

She’s back in that cage, but this time, she’s not playing the helpless victim. She’s stepping into the scene with purpose. We’ve come full circle: back in Gilead, back in ranks, back seeing who ...

Foster City: Gilead Sciences, Inc., a biopharmaceutical company, has received approval from the U.S. Food and Drug Administration (FDA) for Yeztugo (lenacapavir), the company's injectable HIV-1 capsid ...

Gilead’s drug already is sold to treat HIV under the brand name Sunlenca. The prevention dose will be sold under a different name, Yeztugo. It’s given as two injections under the skin of the abdomen, ...

Gilead will cover up to $7,200 annually in out-of-pocket costs for insured people receiving Yeztugo. And its patient assistance program will provide it free to low-income uninsured people.